title: Combined dose-ratio analysis for the CCK-B antagonist virginiamycin in guinea pig ileum.
authors.affiliation: Glaxo Research Laboratories, Verona, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Corsi
authors.forename: G
authors.initials: G
authors.lastname: Dal Forno
authors.forename: B
authors.initials: B
authors.lastname: Oliosi
authors.forename: C
authors.initials: C
authors.lastname: Pietra
authors.forename: F T
authors.initials: FT
authors.lastname: van Amsterdam
authors.forename: D G
authors.initials: DG
authors.lastname: Trist
mesh_terms: D000818:Animals; D001570:Benzodiazepinones / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects / Q000502:physiology*; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D010179:Pancreas / Q000378:metabolism; D010671:Phenylurea Compounds; D051381:Rats; D017207:Rats, Sprague-Dawley; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D013758:Tetragastrin / Q000378:metabolism; D014769:Virginiamycin / Q000378:metabolism / Q000494:pharmacology*
chemical_list: D001570:Benzodiazepinones; D010671:Phenylurea Compounds; D011949:Receptors, Cholecystokinin; D013758:Tetragastrin; D014769:Virginiamycin; C058121:L 365260